Skip to content
Review

Unveiling the role of lysosomes in antigen processing and presentation.

Aug 2026 · Journal of Immunology · Vol 215 8 · 0 citations · 217 references
Medicine

TL;DR

The main mechanisms of antigen acquisition, endocytic/lysosomal factors controlling MHCII-restricted processing and presentation, and evidence linking lysosomal dysfunction to autoimmunity are explored.

Abstract

Lysosomes drive antigen proteolysis and peptide loading for major histocompatibility complex class II (MHCII) presentation in antigen-presenting cells (APCs), enabling activation of peptide-specific CD4+ T helper cells (CD4+ Th cells). Tight regulation of endocytic trafficking, protease activity, and peptide editing is required to generate stable peptide-MHCII complexes and balanced immune responses. Conversely, dysregulation of antigen catabolism or loading can promote impaired pathological immunity, including autoimmunity. However, key mechanistic questions remain, including how proteolysis, redox regulation, and peptide editing shape the MHCII ligandome across APC subsets and inflammatory states. In this review, we explore the main mechanisms of antigen acquisition, endocytic/lysosomal factors controlling MHCII-restricted processing and presentation, and evidence linking lysosomal dysfunction to autoimmunity. Understanding the functions of lysosomes in immune cells is crucial for elucidating their roles in physiological and pathological states, for developing targeted therapeutic strategies and for enhancing the safety and efficacy of novel biological entities (NBEs).

View source

Similar papers

Review Open access Jul 2026

Cysteine Peptidases in Antitumor Immunity: Unraveling Antigen‐Presenting Cell Regulation and Therapeutic Potential

This review systematically summarizes the central role of cysteine peptidases in modulating antigen‐presenting cell (APC) function and antitumor immune responses, highlighting their critical significance in overcoming tumor immune evasion. Current research has established that cysteine peptidase subtypes, including c...

Yi-Mao Wu, Xiao-Yan Chen, Zi-Chang Chen et al. · 0 citations
Review Open access Jul 2026

The race between viral immune evasion and the MHC class I antigen processing pathway

This review describes the development of pathway-centered mechanistic synthesis across DNA and RNA virus families and further integrate innate immune antagonism, endoplasmic reticulum stress, antigen-presentation competence, cross-presentation limits, and virus-shaped peptide landscapes into a unified framework for und...

Yu Ye, Ying Zhang, Haobing Nie et al. · 0 citations
Open access Aug 2026

Sorting nexin 5 deficiency impairs MHC class II antigen presentation and inflammatory responses during tuberculosis

This work identifies SNX5 as a regulator of MHC class II antigen presentation that influences inflammatory outcomes during pulmonary Mtb infection and identifies SNX5 as a regulator of MHC class II antigen presentation that influences inflammatory outcomes during pulmonary Mtb infection.

Beatriz R. S. Dias, Kubra F. Naqvi, Victoria A. Ektnitphong et al. · 0 citations
Open access Aug 2026

Improved cross-presentation enabled by fusion-dependent mini-proteins that efficiently reach the dendritic cell cytosol

It is shown that substantive improvements in cytosolic antigen delivery provided by the fusion-dependent mini-protein ZF5.3 result in concomitant improvements in MHC-I-mediated antigen presentation and B3Z T-cell activation, which could improve the design of peptide vaccines for immunotherapy.

Teresia Chen, Michel DuPage, Alanna Schepartz · 0 citations
Review Jul 2026

Peptide Loading Complex in Cancer: From Peptide Translocation, Editing, and Loading into MHC-I to a Potential Therapeutic Target

An overview of the PLC as a major determinant of tumor immune escape and a potential therapy target is provided and existing or evolving therapeutic approaches to recover/reprogram PLC functions are explored.

O. Allela, Abdulkareem Shareef, Hayder Naji Sameer et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.